{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:35:38Z","timestamp":1795012538416,"version":"4.9.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8098","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,1,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Targeted protein degradation is a pharmacological strategy that relies on small molecules such as proteolysis-targeting chimeras (PROTACs) or molecular glues, which induce proximity between a target protein and an E3 ubiquitin ligase to prompt target ubiquitination and proteasomal degradation\n                    <jats:sup>1<\/jats:sup>\n                    . Sporadic reports indicated that ligands designed to inhibit a target can also induce its destabilization\n                    <jats:sup>2\u20134<\/jats:sup>\n                    . Among others, this has repeatedly been observed for kinase inhibitors\n                    <jats:sup>5\u20137<\/jats:sup>\n                    . However, we lack an understanding of the frequency, generalizability and mechanistic underpinnings of these phenomena. Here, to address this knowledge gap, we generated dynamic abundance profiles of 98 kinases after cellular perturbations with 1,570 kinase inhibitors, revealing 160 selective instances of inhibitor-induced kinase destabilization. Kinases prone to degradation are frequently annotated as HSP90 clients, therefore affirming chaperone deprivation as an important route of destabilization. However, detailed investigation of inhibitor-induced degradation of LYN, BLK and RIPK2 revealed a differentiated, common mechanistic logic whereby inhibitors function by inducing a kinase state that is more efficiently cleared by endogenous degradation mechanisms. Mechanistically, effects can manifest by ligand-induced changes in cellular activity, localization or higher-order assemblies, which may be triggered by direct target engagement or network effects. Collectively, our data suggest that inhibitor-induced kinase degradation is a common event and positions supercharging of endogenous degradation circuits as an alternative to classical proximity-inducing degraders.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09763-9","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:03:47Z","timestamp":1764173027000},"page":"1032-1041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Inhibitors supercharge kinase turnover through native proteolytic circuits"],"prefix":"10.1038","volume":"649","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-4079","authenticated-orcid":false,"given":"Natalie S.","family":"Scholes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9633-7665","authenticated-orcid":false,"given":"Arnau","family":"Comajuncosa-Creus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kladnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7135-0954","authenticated-orcid":false,"given":"Xuefei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-8005","authenticated-orcid":false,"given":"Fabian","family":"Frommelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-4690","authenticated-orcid":false,"given":"Matthias","family":"Hinterndorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-8172","authenticated-orcid":false,"given":"Hlib","family":"Razumkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Prokofeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-1829","authenticated-orcid":false,"given":"Martin P.","family":"Schwalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3999-712X","authenticated-orcid":false,"given":"Sandra","family":"Roehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-1823","authenticated-orcid":false,"given":"Hana","family":"Imrichova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianda L.","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-7070","authenticated-orcid":false,"given":"Eleonora","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sch\u00e4tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4391-6393","authenticated-orcid":false,"given":"Miquel","family":"Mu\u00f1oz i Ordo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-9360","authenticated-orcid":false,"given":"Andrea","family":"Rukavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iciar","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-2999","authenticated-orcid":false,"given":"Miriam","family":"Abele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-4970","authenticated-orcid":false,"given":"Anna","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-8343","authenticated-orcid":false,"given":"Stefan","family":"Kubicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-6494","authenticated-orcid":false,"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-7403","authenticated-orcid":false,"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-1768","authenticated-orcid":false,"given":"Giulio","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9094-1677","authenticated-orcid":false,"given":"Bernhard","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-168X","authenticated-orcid":false,"given":"Yigong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3557-0236","authenticated-orcid":false,"given":"Patrick","family":"Aloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-1437","authenticated-orcid":false,"given":"Georg E.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"9763_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer, M., Spiteri, V. A., Ciulli, A. & Winter, G. E. Targeted protein degradation for cancer therapy. Nat. Rev. Cancer 25, 493\u2013516 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"9763_CR2","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","volume":"20","author":"N Kerres","year":"2017","unstructured":"Kerres, N. et al. Chemically induced degradation of the oncogenic transcription factor BCL6. Cell Rep. 20, 2860\u20132875 (2017).","journal-title":"Cell Rep."},{"key":"9763_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-020-2925-1","volume":"588","author":"M S\u0142abicki","year":"2020","unstructured":"S\u0142abicki, M. et al. Small-molecule-induced polymerization triggers degradation of BCL6. Nature 588, 164\u2013168 (2020).","journal-title":"Nature"},{"key":"9763_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embj.201694058","volume":"36","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination. EMBO J. 36, 1243\u20131260 (2017).","journal-title":"EMBO J."},{"key":"9763_CR5","doi-asserted-by":"publisher","first-page":"e60961","DOI":"10.1371\/journal.pone.0060961","volume":"8","author":"D D\u2019allard","year":"2013","unstructured":"D\u2019allard, D. et al. Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket. PLoS ONE 8, e60961 (2013).","journal-title":"PLoS ONE"},{"key":"9763_CR6","doi-asserted-by":"publisher","first-page":"33897","DOI":"10.1038\/srep33897","volume":"6","author":"E Lobbestael","year":"2016","unstructured":"Lobbestael, E. et al. Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation. Sci. Rep. 6, 33897\u201333897 (2016).","journal-title":"Sci. Rep."},{"key":"9763_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.chembiol.2017.10.011","volume":"25","author":"LH Jones","year":"2018","unstructured":"Jones, L. H. Small-molecule kinase downregulators. Cell Chem. Biol. 25, 30\u201335 (2018).","journal-title":"Cell Chem. Biol."},{"key":"9763_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","volume":"150","author":"M Taipale","year":"2012","unstructured":"Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150, 987\u20131001 (2012).","journal-title":"Cell"},{"key":"9763_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nbt.2620","volume":"31","author":"M Taipale","year":"2013","unstructured":"Taipale, M. et al. Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells. Nat. Biotechnol. 31, 630\u2013637 (2013).","journal-title":"Nat. Biotechnol."},{"key":"9763_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2016.08.026","volume":"382","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells. Cancer Lett. 382, 176\u2013185 (2016).","journal-title":"Cancer Lett."},{"key":"9763_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc3099","volume":"6","author":"A Ditsiou","year":"2020","unstructured":"Ditsiou, A. et al. The structure-function relationship of oncogenic LMTK3. Sci. Adv. 6, eabc3099 (2020).","journal-title":"Sci. Adv."},{"key":"9763_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nchembio.1212","volume":"9","author":"S Polier","year":"2013","unstructured":"Polier, S. et al. ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system. Nat. Chem. Biol. 9, 307\u2013312 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"9763_CR13","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1021\/acs.jmedchem.2c01422","volume":"65","author":"EJ Hanan","year":"2022","unstructured":"Hanan, E. J. et al. Discovery of GDC-0077 (inavolisib), a highly selective inhibitor and degrader of mutant PI3K\u03b1. J. Med. Chem. 65, 16589\u201316621 (2022).","journal-title":"J. Med. Chem."},{"key":"9763_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/2159-8290.CD-21-0072","volume":"12","author":"KW Song","year":"2022","unstructured":"Song, K. W. et al. RTK-Dependent inducible degradation of mutant PI3K\u03b1 drives GDC-0077 (inavolisib) efficacy. Cancer Discov. 12, 204\u2013219 (2022).","journal-title":"Cancer Discov."},{"key":"9763_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nbt1358","volume":"26","author":"MW Karaman","year":"2008","unstructured":"Karaman, M. W. et al. A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 26, 127\u2013132 (2008).","journal-title":"Nat. Biotechnol."},{"key":"9763_CR16","doi-asserted-by":"publisher","first-page":"29230","DOI":"10.1074\/jbc.M703461200","volume":"282","author":"I Plaza-Menacho","year":"2007","unstructured":"Plaza-Menacho, I. et al. Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting. J. Biol. Chem. 282, 29230\u201329240 (2007).","journal-title":"J. Biol. Chem."},{"key":"9763_CR17","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.0500410102","volume":"102","author":"N Watanabe","year":"2005","unstructured":"Watanabe, N. et al. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc. Natl Acad. Sci. USA 102, 11663\u201311668 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9763_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107059","volume":"200","author":"R Roskoski","year":"2024","unstructured":"Roskoski, R. Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update. Pharmacol. Res. 200, 107059 (2024).","journal-title":"Pharmacol. Res."},{"key":"9763_CR19","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2020.10.038","volume":"183","author":"KA Donovan","year":"2020","unstructured":"Donovan, K. A. et al. Mapping the degradable kinome provides a resource for expedited degrader development. Cell 183, 1714\u20131731 (2020).","journal-title":"Cell"},{"key":"9763_CR20","doi-asserted-by":"publisher","first-page":"33602","DOI":"10.18632\/oncotarget.5286","volume":"6","author":"K Yonesaka","year":"2015","unstructured":"Yonesaka, K. et al. The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget 6, 33602\u201333611 (2015).","journal-title":"Oncotarget"},{"key":"9763_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/2159-8290.CD-20-0215","volume":"10","author":"BT Li","year":"2020","unstructured":"Li, B. T. et al. HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers. Cancer Discov. 10, 674\u2013687 (2020).","journal-title":"Cancer Discov."},{"key":"9763_CR22","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/jcb.23147","volume":"112","author":"T Suzuki","year":"2011","unstructured":"Suzuki, T., Fujii, A., Ochi, H. & Nakamura, H. Ubiquitination and downregulation of ErbB2 and estrogen receptor-alpha by kinase inhibitor MP-412 in human breast cancer cells. J. Cell. Biochem. 112, 2279\u20132286 (2011).","journal-title":"J. Cell. Biochem."},{"key":"9763_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/acs.jmedchem.1c01186","volume":"65","author":"R Liu","year":"2022","unstructured":"Liu, R., Zhan, S., Che, Y. & Shen, J. Reactivities of the front pocket N-terminal cap cysteines in human kinases. J. Med. Chem. 65, 1525\u20131535 (2022).","journal-title":"J. Med. Chem."},{"key":"9763_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41587-020-0502-7","volume":"38","author":"M Duran-Frigola","year":"2020","unstructured":"Duran-Frigola, M. et al. Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker. Nat. Biotechnol. 38, 1087\u20131096 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9763_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molcel.2007.11.019","volume":"28","author":"T Hunter","year":"2007","unstructured":"Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730\u2013738 (2007).","journal-title":"Mol. Cell"},{"key":"9763_CR26","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1021\/acsmedchemlett.9b00354","volume":"10","author":"DP O\u2019Malley","year":"2019","unstructured":"O\u2019Malley, D. P. et al. Discovery of pyridazinone and pyrazolo[1,5-a]pyridine inhibitors of C-terminal Src kinase. ACS Med. Chem. Lett. 10, 1486\u20131491 (2019).","journal-title":"ACS Med. Chem. Lett."},{"key":"9763_CR27","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1021\/jm2008634","volume":"54","author":"T Ishikawa","year":"2011","unstructured":"Ishikawa, T. et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)\/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. J. Med. Chem. 54, 8030\u20138050 (2011).","journal-title":"J. Med. Chem."},{"key":"9763_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1021\/acsmedchemlett.7b00258","volume":"8","author":"X He","year":"2017","unstructured":"He, X. et al. Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases. ACS Med. Chem. Lett. 8, 1048\u20131053 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"9763_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","volume":"627","author":"O Hsia","year":"2024","unstructured":"Hsia, O. et al. Targeted protein degradation via intramolecular bivalent glues. Nature 627, 204\u2013211 (2024).","journal-title":"Nature"},{"key":"9763_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1128\/MCB.20.3.851-867.2000","volume":"20","author":"CE Andoniou","year":"2000","unstructured":"Andoniou, C. E. et al. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol. Cell. Biol. 20, 851\u2013867 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"9763_CR31","doi-asserted-by":"publisher","first-page":"35185","DOI":"10.1074\/jbc.M102219200","volume":"276","author":"M Yokouchi","year":"2001","unstructured":"Yokouchi, M. et al. Src-catalyzed phosphorylation of c-Cbl Leads to the interdependent ubiquitination of both proteins. J. Biol. Chem. 276, 35185\u201335193 (2001).","journal-title":"J. Biol. Chem."},{"key":"9763_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1365-2443.2003.00679.x","volume":"8","author":"S Kyo","year":"2003","unstructured":"Kyo, S. et al. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation. Genes Cells 8, 825\u2013836 (2003).","journal-title":"Genes Cells"},{"key":"9763_CR33","doi-asserted-by":"publisher","first-page":"e46043","DOI":"10.7554\/eLife.46043","volume":"8","author":"BF Brian IV","year":"2019","unstructured":"Brian, B. F. IV et al. Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells. eLife 8, e46043 (2019).","journal-title":"eLife"},{"key":"9763_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux, K. J., Kim, D. I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801\u2013810 (2012).","journal-title":"J. Cell Biol."},{"key":"9763_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-021-03592-2","volume":"595","author":"CD Go","year":"2021","unstructured":"Go, C. D. et al. A proximity-dependent biotinylation map of a human cell. Nature 595, 120\u2013124 (2021).","journal-title":"Nature"},{"key":"9763_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-14-0552","volume":"5","author":"MM Martins","year":"2015","unstructured":"Martins, M. M. et al. Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Cancer Discov. 5, 154\u2013167 (2015).","journal-title":"Cancer Discov."},{"key":"9763_CR37","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1021\/cb500371g","volume":"9","author":"SE Leonard","year":"2014","unstructured":"Leonard, S. E., Register, A. C., Krishnamurty, R., Brighty, G. J. & Maly, D. J. Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors. ACS Chem. Biol. 9, 1894\u20131905 (2014).","journal-title":"ACS Chem. Biol."},{"key":"9763_CR38","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022\u20133040 (2021).","journal-title":"Cell"},{"key":"9763_CR39","doi-asserted-by":"publisher","first-page":"eaan4368","DOI":"10.1126\/science.aan4368","volume":"358","author":"S Klaeger","year":"2017","unstructured":"Klaeger, S. et al. The target landscape of clinical kinase drugs. Science 358, eaan4368 (2017).","journal-title":"Science"},{"key":"9763_CR40","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1021\/acschembio.4c00432","volume":"19","author":"K Tahara","year":"2024","unstructured":"Tahara, K. et al. \u03b3-Secretase cleaves bifunctional fatty acid-conjugated small molecules with amide bonds in mammalian cells. ACS Chem. Biol. 19, 2438\u20132450 (2024).","journal-title":"ACS Chem. Biol."},{"key":"9763_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0092-8674(94)90104-X","volume":"76","author":"MD Resh","year":"1994","unstructured":"Resh, M. D. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76, 411\u2013413 (1994).","journal-title":"Cell"},{"key":"9763_CR42","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.4049\/jimmunol.165.6.3226","volume":"165","author":"K Yasuda","year":"2000","unstructured":"Yasuda, K. et al. Serine 6 of Lck tyrosine kinase: a critical site for Lck myristoylation, membrane localization, and function in T lymphocytes. J. Immunol. 165, 3226\u20133231 (2000).","journal-title":"J. Immunol."},{"key":"9763_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"9763_CR44","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.4049\/jimmunol.178.4.2380","volume":"178","author":"J-H Park","year":"2007","unstructured":"Park, J.-H. et al. RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380\u20132386 (2007).","journal-title":"J. Immunol."},{"key":"9763_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20061704","volume":"404","author":"M Windheim","year":"2007","unstructured":"Windheim, M., Lang, C., Peggie, M., Plater, L. A. & Cohen, P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J 404, 179\u2013190 (2007).","journal-title":"Biochem. J"},{"key":"9763_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat. Chem. Biol. 11, 611\u2013617 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"9763_CR47","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1016\/j.molcel.2022.07.006","volume":"82","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. TMUB1 is an endoplasmic reticulum-resident escortase that promotes the p97-mediated extraction of membrane proteins for degradation. Mol. Cell 82, 3453\u20133467 (2022).","journal-title":"Mol. Cell"},{"key":"9763_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1083\/jcb.200712064","volume":"181","author":"T Hara","year":"2008","unstructured":"Hara, T. et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol. 181, 497\u2013510 (2008).","journal-title":"J. Cell Biol."},{"key":"9763_CR49","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/15548627.2023.2166724","volume":"19","author":"S Mehto","year":"2023","unstructured":"Mehto, S., Kundu, S., Chauhan, S. & Chauhan, S. RIPosomes are targets of IRGM-SQSTM1-dependent autophagy. Autophagy 19, 1045\u20131047 (2023).","journal-title":"Autophagy"},{"key":"9763_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07447-9","volume":"9","author":"Q Gong","year":"2018","unstructured":"Gong, Q. et al. Structural basis of RIP2 activation and signaling. Nat. Commun. 9, 4993 (2018).","journal-title":"Nat. Commun."},{"key":"9763_CR51","doi-asserted-by":"publisher","first-page":"e201900346","DOI":"10.26508\/lsa.201900346","volume":"2","author":"K Ellwanger","year":"2019","unstructured":"Ellwanger, K. et al. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures. Life Sci. Alliance 2, e201900346 (2019).","journal-title":"Life Sci. Alliance"},{"key":"9763_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell, D. C. et al. A proteome-wide atlas of drug mechanism of action. Nat. Biotechnol. 41, 845\u2013857 (2023).","journal-title":"Nat. Biotechnol."},{"key":"9763_CR53","doi-asserted-by":"publisher","unstructured":"Eckert, S. et al. Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-024-02218-y (2024).","DOI":"10.1038\/s41587-024-02218-y"},{"key":"9763_CR54","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","volume":"272","author":"DB Whyte","year":"1997","unstructured":"Whyte, D. B. et al. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272, 14459\u201314464 (1997).","journal-title":"J. Biol. Chem."},{"key":"9763_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41573-020-0068-6","volume":"19","author":"AR Moore","year":"2020","unstructured":"Moore, A. R., Rosenberg, S. C., McCormick, F. & Malek, S. RAS-targeted therapies: is the undruggable drugged?. Nat. Rev. Drug Discov. 19, 533\u2013552 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9763_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09358-9","volume":"10","author":"KR Simonetta","year":"2019","unstructured":"Simonetta, K. R. et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat. Commun. 10, 1402 (2019).","journal-title":"Nat. Commun."},{"key":"9763_CR57","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molcel.2023.06.028","volume":"83","author":"JM Tsai","year":"2023","unstructured":"Tsai, J. M. et al. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability. Mol. Cell 83, 2753\u20132767 (2023).","journal-title":"Mol. Cell"},{"key":"9763_CR58","doi-asserted-by":"publisher","unstructured":"Hennes, E. et al. Monovalent pseudo-natural product degraders supercharge the native degradation of IDO1 by KLHDC3. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.10.602857 (2024).","DOI":"10.1101\/2024.07.10.602857"},{"key":"9763_CR59","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nature09627","volume":"468","author":"CM Johannessen","year":"2010","unstructured":"Johannessen, C. M. et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468, 968\u2013972 (2010).","journal-title":"Nature"},{"key":"9763_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nmeth.1638","volume":"8","author":"X Yang","year":"2011","unstructured":"Yang, X. et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8, 659\u2013661 (2011).","journal-title":"Nat. Methods"},{"key":"9763_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1073\/pnas.2235688100","volume":"101","author":"T Matsuda","year":"2004","unstructured":"Matsuda, T. & Cepko, C. L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl Acad. Sci. USA 101, 16\u201322 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9763_CR62","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41592-020-0850-8","volume":"17","author":"G Michlits","year":"2020","unstructured":"Michlits, G. et al. Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles. Nat. Methods 17, 708\u2013716 (2020).","journal-title":"Nat. Methods"},{"key":"9763_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12859-016-1433-7","volume":"18","author":"S Eid","year":"2017","unstructured":"Eid, S., Turk, S., Volkamer, A., Rippmann, F. & Fulle, S. KinMap: a web-based tool for interactive navigation through human kinome data. BMC Bioinform. 18, 16 (2017).","journal-title":"BMC Bioinform."},{"key":"9763_CR64","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/molecules23040908","volume":"23","author":"F Carles","year":"2018","unstructured":"Carles, F., Bourg, S., Meyer, C. & Bonnet, P. PKIDB: a curated, annotated and updated database of protein kinase inhibitors in clinical trials. Molecules 23, 908 (2018).","journal-title":"Molecules"},{"key":"9763_CR65","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3390\/molecules25143226","volume":"25","author":"C Bournez","year":"2020","unstructured":"Bournez, C. et al. Comparative assessment of protein kinase inhibitors in public databases and in PKIDB. Molecules 25, 3226 (2020).","journal-title":"Molecules"},{"key":"9763_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49739-3","volume":"15","author":"C Kagiou","year":"2024","unstructured":"Kagiou, C. et al. Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nat. Commun. 15, 5409 (2024).","journal-title":"Nat. Commun."},{"key":"9763_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41586-021-04035-8","volume":"599","author":"M de Almeida","year":"2021","unstructured":"de Almeida, M. et al. AKIRIN2 controls the nuclear import of proteasomes in vertebrates. Nature 599, 491\u2013496 (2021).","journal-title":"Nature"},{"key":"9763_CR68","doi-asserted-by":"publisher","unstructured":"Broad DepMap Team. DepMap 20Q1 public. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.11791698.v3 (2020).","DOI":"10.6084\/m9.figshare.11791698.v3"},{"key":"9763_CR69","doi-asserted-by":"publisher","unstructured":"Hanzl, A. et al. Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-022-01177-2 (2022).","DOI":"10.1038\/s41589-022-01177-2"},{"key":"9763_CR70","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"9763_CR71","doi-asserted-by":"publisher","unstructured":"Schwalm, M. P., Saxena, K., M\u00fcller, S. & Knapp, S. Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells. Nat. Protoc. https:\/\/doi.org\/10.1038\/s41596-024-00979-z (2024).","DOI":"10.1038\/s41596-024-00979-z"},{"key":"9763_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49896-5","volume":"15","author":"M Schwalm","year":"2024","unstructured":"Schwalm, M. et al. tracerDB: a crowdsourced fluorescent tracer database for target engagement analysis. Nat. Commun. 15, 5646 (2024).","journal-title":"Nat. Commun."},{"key":"9763_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature14892","volume":"525","author":"X Bai","year":"2015","unstructured":"Bai, X. et al. An atomic structure of human \u03b3-secretase. Nature 525, 212\u2013217 (2015).","journal-title":"Nature"},{"key":"9763_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk5864","volume":"384","author":"F Offensperger","year":"2024","unstructured":"Offensperger, F. et al. Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science 384, eadk5864 (2024).","journal-title":"Science"},{"key":"9763_CR75","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"9763_CR76","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/pmic.201000722","volume":"11","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics 11, 2019\u20132026 (2011).","journal-title":"Proteomics"},{"key":"9763_CR77","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/pmic.201500499","volume":"16","author":"G Teo","year":"2016","unstructured":"Teo, G. et al. SAINTq: scoring protein-protein interactions in affinity purification\u2013mass spectrometry experiments with fragment or peptide intensity data. Proteomics 16, 2238\u20132245 (2016).","journal-title":"Proteomics"},{"key":"9763_CR78","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nmeth.2557","volume":"10","author":"D Mellacheruvu","year":"2013","unstructured":"Mellacheruvu, D. et al. The CRAPome: a contaminant repository for affinity purification\u2013mass spectrometry data. Nat. Methods 10, 730\u2013736 (2013).","journal-title":"Nat. Methods"},{"key":"9763_CR79","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1021\/acschembio.8b01020","volume":"14","author":"M Reinecke","year":"2019","unstructured":"Reinecke, M. et al. Chemoproteomic selectivity profiling of PIKK and PI3K kinase inhibitors. ACS Chem. Biol. 14, 655\u2013664 (2019).","journal-title":"ACS Chem. Biol."},{"key":"9763_CR80","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41589-022-01015-5","volume":"18","author":"S Lechner","year":"2022","unstructured":"Lechner, S. et al. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. Nat. Chem. Biol. 18, 812\u2013820 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"9763_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4939-6747-6_8","volume":"1550","author":"B Ruprecht","year":"2017","unstructured":"Ruprecht, B., Zecha, J., Zolg, D. P. & Kuster, B. High pH reversed-phase micro-columns for simple, sensitive, and efficient fractionation of proteome and (TMT labeled) phosphoproteome digests. Methods Mol. Biol. 1550, 83\u201398 (2017).","journal-title":"Methods Mol. Biol."},{"key":"9763_CR82","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"9763_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43696-z","volume":"14","author":"FP Bayer","year":"2023","unstructured":"Bayer, F. P., Gander, M., Kuster, B. & The, M. CurveCurator: a recalibrated F-statistic to assess, classify, and explore significance of dose\u2013response curves. Nat. Commun. 14, 7902 (2023).","journal-title":"Nat. Commun."},{"key":"9763_CR84","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09763-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09763-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09763-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:03:34Z","timestamp":1769220214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09763-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":84,"journal-issue":{"issue":"8098","published-print":{"date-parts":[[2026,1,22]]}},"alternative-id":["9763"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09763-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.10.602881","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Kubicek, G.S.-F. and G.E.W. are scientific founders and shareholders of Proxygen and Solgate and shareholders in Cellgate Therapeutics. G.E.W. is on the scientific advisory board of Nexo Therapeutics. The G.E.W. and G.S.-F. laboratories received research funding from Pfizer. B.K. is a founder and shareholder of OmicScouts and MSAID. He has no operational role in either company. N.S.G. is a founder, scientific advisory board member and equity holder in Syros, C4, Allorion, Lighthorse, Voronoi, Inception, Matchpoint, CobroVentures, GSK, Shenandoah (board member), Larkspur (board member) and Soltego (board member). The Gray laboratory receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Jansen, Kinogen, Arbella, Deerfield, Springworks, Interline and Sanofi. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}